Literature DB >> 32109279

Clinical Characteristics of Imported Cases of Coronavirus Disease 2019 (COVID-19) in Jiangsu Province: A Multicenter Descriptive Study.

Jian Wu1,2, Jun Liu3, Xinguo Zhao4, Chengyuan Liu5, Wei Wang2, Dawei Wang6, Wei Xu7, Chunyu Zhang8, Jiong Yu1, Bin Jiang9, Hongcui Cao1,10, Lanjuan Li1.   

Abstract

BACKGROUND: We aimed to report the clinical characteristics of imported cases of coronavirus disease 2019 (COVID-19) in Jiangsu Province.
METHODS: We retrospectively investigated the clinical, imaging, and laboratory characteristics of confirmed cases of COVID-19 with World Health Organization interim guidance in 3 grade IIIA hospitals of Jiangsu from 22 January to 14 February 2020. Real-time RT-PCR was used to detect the new coronavirus in respiratory samples.
RESULTS: Of the 80 patients infected with COVID-19, 41 were female, with a median age of 46.1 years. Except for 3 severe patients, the rest of the 77 patients exhibited mild or moderate symptoms. Nine patients were unconfirmed until a third nucleic acid test; 38 cases had a history of chronic diseases. The main clinical manifestations of the patients were fever and cough, which accounted for 63 (78.75%) and 51 (63.75%) cases, respectively. Only 3 patients (3.75%) showed liver dysfunction. Imaging examination showed that 55 patients (68.75%) showed abnormal density shadow and 25 cases (31.25%) had no abnormal density shadow in the parenchyma of both lungs. Currently, 21 cases have been discharged from the hospital, and no patient died. The average length of stay for discharged patients was 8 days.
CONCLUSIONS: Compared with the cases in Wuhan, the cases in Jiangsu exhibited mild or moderate symptoms and no obvious gender susceptibility. The proportion of patients having liver dysfunction and abnormal CT imaging was relatively lower than that in Wuhan. Notably, infected patients may be falsely excluded based on 2 consecutively negative respiratory pathogenic nucleic acid test results.
© The Author(s) 2020. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  clinical characteristics; coronavirus disease 2019 (COVID-19); imported cases; pneumonia

Mesh:

Year:  2020        PMID: 32109279      PMCID: PMC7108195          DOI: 10.1093/cid/ciaa199

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  234 in total

1.  Clinical Features of COVID-19 and Factors Associated with Severe Clinical Course: A Systematic Review and Meta-Analysis.

Authors:  Ashish Kumar; Anil Arora; Praveen Sharma; Shrihari Anil Anikhindi; Naresh Bansal; Vikas Singla; Shivam Khare; Abhishyant Srivastava
Journal:  SSRN       Date:  2020-04-21

2.  COVID-19 Serosurveillance May Facilitate Return-to-Work Decisions.

Authors:  Martin Krsak; Steven C Johnson; Eric M Poeschla
Journal:  Am J Trop Med Hyg       Date:  2020-06       Impact factor: 2.345

3.  Controversies' clarification regarding ribavirin efficacy in measles and coronaviruses: Comprehensive therapeutic approach strictly tailored to COVID-19 disease stages.

Authors:  George D Liatsos
Journal:  World J Clin Cases       Date:  2021-07-06       Impact factor: 1.337

Review 4.  Coronavirus disease 2019 (COVID-19): research progress and clinical practice.

Authors:  Satoshi Kutsuna
Journal:  Glob Health Med       Date:  2020-04-30

5.  Incidence of myocardial injury in coronavirus disease 2019 (COVID-19): a pooled analysis of 7,679 patients from 53 studies.

Authors:  Zhi-Chun Gu; Chi Zhang; Ling-Cong Kong; Long Shen; Zheng Li; Heng Ge; Hou-Wen Lin; Jun Pu
Journal:  Cardiovasc Diagn Ther       Date:  2020-08

6.  ARIMA models for predicting the end of COVID-19 pandemic and the risk of second rebound.

Authors:  Zohair Malki; El-Sayed Atlam; Ashraf Ewis; Guesh Dagnew; Ahmad Reda Alzighaibi; Ghada ELmarhomy; Mostafa A Elhosseini; Aboul Ella Hassanien; Ibrahim Gad
Journal:  Neural Comput Appl       Date:  2020-10-23       Impact factor: 5.606

7.  Effect of Tocilizumab vs Usual Care in Adults Hospitalized With COVID-19 and Moderate or Severe Pneumonia: A Randomized Clinical Trial.

Authors:  Olivier Hermine; Xavier Mariette; Pierre-Louis Tharaux; Matthieu Resche-Rigon; Raphaël Porcher; Philippe Ravaud
Journal:  JAMA Intern Med       Date:  2021-01-01       Impact factor: 21.873

Review 8.  [Coronavirus disease 2019 (COVID-19): update for anesthesiologists and intensivists March 2020].

Authors:  D Thomas-Rüddel; J Winning; P Dickmann; D Ouart; A Kortgen; U Janssens; M Bauer
Journal:  Anaesthesist       Date:  2020-04       Impact factor: 1.041

Review 9.  A systematic review of chest imaging findings in COVID-19.

Authors:  Zhonghua Sun; Nan Zhang; Yu Li; Xunhua Xu
Journal:  Quant Imaging Med Surg       Date:  2020-05

Review 10.  Upper respiratory tract and otolaryngological manifestations of coronavirus disease 2019 (COVID-19): A systemic review.

Authors:  Jamil N Al-Swiahb; Mohammed A Motiwala
Journal:  SAGE Open Med       Date:  2021-05-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.